Tefen worked with a major pharmaceutical company to accommodate growth while reducing costs in the QA organisation. A roadmap of recommendations was produced to cope with increasing workloads with current headcount.
Having received a large amount of investment, the company is coming under increasing pressure to deliver cost effective products. Increased volume, complexity of products and tighter resources will place greater demands on QA function in the near future; impacting on operational, problem solving and managerial activities. The challenge is to enable the QA organisation to cope with the increased production planned in the next 2 years, while keeping a level headcount.
Tefen supported Process Optimisation by:
Process improvement recommendations to reduce the estimated 2013 workload from 80 to 66 FTE’s and 2014 workload from 100 to 81 FTE’s. Identification and quantification of a further 4.5 FTE’s workload that could be absorbed with increased employee efficiency, as well as further un-quantified recommendations for quality improvements.